{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:14:08Z","timestamp":1791112448161,"version":"4.1.0"},"reference-count":34,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T00:00:00Z","timestamp":1256083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>HIV\u2010infected patients show an increased cardiovascular disease (CVD) risk resulting, essentially, from metabolic disturbances related to chronic infection and antiretroviral treatments. The aims of this study were: (1) to evaluate the agreement between the CVD risk estimated using the Framingham risk score (FRS) and the observed presence of subclinical atherosclerosis in HIV\u2010infected patients; (2) to investigate the relationships between CVD and plasma biomarkers of oxidation and inflammation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Atherosclerosis was evaluated in 187 HIV\u2010infected patients by measuring the carotid intima\u2010media thickness (CIMT). CVD risk was estimated using the FRS. We also measured the circulating levels of interleukin\u20106, monocyte chemoattractant protein\u20101 (MCP\u20101) and oxidized low\u2010density lipoprotein (LDL), and paraoxonase\u20101 activity and concentration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There was a weak, albeit statistically significant, agreement between FRS and CIMT (\u03ba=0.229, <jats:italic>P<\/jats:italic>&lt;0.001). A high proportion of patients with an estimated low risk had subclinical atherosclerosis (<jats:italic>n<\/jats:italic>=66; 56.4%). In a multivariate analysis, the presence of subclinical atherosclerosis in this subgroup of patients was associated with age [odds ratio (OR) 1.285; 95% confidence interval (CI) 1.084\u20131.524; <jats:italic>P<\/jats:italic>=0.004], body mass index (OR 0.799; 95% CI 0.642\u20130.994; <jats:italic>P<\/jats:italic>=0.044), MCP\u20101 (OR 1.027; 95% CI 1.004\u20131.050; <jats:italic>P<\/jats:italic>=0.020) and oxidized LDL (OR 1.026; 95% CI 1.001\u20131.051; <jats:italic>P<\/jats:italic>=0.041).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>FRS underestimated the presence of subclinical atherosclerosis in HIV\u2010infected patients. The increased CVD risk was related, in part, to the chronic oxidative stress and inflammatory status associated with this patient population.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2009.00766.x","type":"journal-article","created":{"date-parts":[[2009,10,22]],"date-time":"2009-10-22T03:42:16Z","timestamp":1256182936000},"page":"225-231","source":"Crossref","is-referenced-by-count":85,"title":["Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV\u2010infected patients: relationships with serum markers of oxidation and inflammation"],"prefix":"10.1111","volume":"11","author":[{"given":"S","family":"Parra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Coll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Aragon\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Marsillach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Joven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Alonso\u2010Villaverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Camps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381301"},{"key":"e_1_2_6_3_2","first-page":"48","article-title":"Medical Progress","volume":"352","author":"Grinspoon SK.","year":"2005","journal-title":"cardiovascular risk and body-fat abnormalities in HIV-infected adults"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199807000-00003"},{"key":"e_1_2_6_5_2","first-page":"641","article-title":"Oxidative stress during viral infection","volume":"21","author":"Schwarz B.","year":"1996","journal-title":"a review"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062744"},{"key":"e_1_2_6_7_2","first-page":"S79","article-title":"HIV and antiretroviral therapy","volume":"49","author":"Kotler DP.","year":"2008","journal-title":"lipid abnormalities and associated cardiovascular risk in HIV-infected patients"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200311210-00010"},{"key":"e_1_2_6_9_2","first-page":"53E","article-title":"Recent national cholesterol education program adult treatment panel III update","volume":"96","author":"Stone NJ","year":"2005","journal-title":"adjustments and options"},{"key":"e_1_2_6_10_2","first-page":"613","article-title":"Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)\u2010infected adults receiving antiretroviral therapy","volume":"37","author":"Dub\u00e9 MP","year":"2003","journal-title":"recommendations of the HIV medical association of the infectious disease society of America and the adult AIDS clinical trials group"},{"key":"e_1_2_6_11_2","first-page":"2026","article-title":"Lifestyle interventions reduce coronary heart disease risk","volume":"119","author":"Maruthur NM","year":"2009","journal-title":"results from the PREMIER trial"},{"key":"e_1_2_6_12_2","first-page":"805","article-title":"Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus","volume":"119","author":"Worm SW","year":"2009","journal-title":"the data collection on adverse events of anti-HIV drugs (D:A:D study)"},{"key":"e_1_2_6_13_2","first-page":"33","article-title":"Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice","volume":"57","author":"De Socio GV","year":"2008","journal-title":"results from the SIMONE study"},{"key":"e_1_2_6_14_2","first-page":"452","article-title":"Global cardiovascular risk in patients with HIV infection","volume":"21","author":"Knobel H","year":"2007","journal-title":"concordance and differences in estimates according to three risk equations (Framingham, SCORE, and PROCAM)"},{"key":"e_1_2_6_15_2","first-page":"625","article-title":"Elevated Framingham risk score in HIV\u2010positive patients on highly active antiretroviral therapy","volume":"23","author":"Bergersen BM","year":"2004","journal-title":"results from a Norwegian study of 721 subjects"},{"key":"e_1_2_6_16_2","first-page":"198","article-title":"State of the science conference","volume":"118","author":"Grinspoon SK","year":"2008","journal-title":"initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV\/AIDS. Executive summary"},{"key":"e_1_2_6_17_2","first-page":"459","article-title":"Prediction of clinical cardiovascular events with carotid intima\u2010media thickness","volume":"115","author":"Lorenz MW","year":"2007","journal-title":"a systematic review and meta-analysis"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000124480.32233.8A"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.106.479030"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.10.066"},{"key":"e_1_2_6_21_2","first-page":"24","article-title":"Inflammation in atherosclerosis","volume":"54","author":"Packard RR","year":"2008","journal-title":"from vascular biology to biomarker discovery and risk prediction"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000143835.95029.7D"},{"key":"e_1_2_6_23_2","first-page":"51","article-title":"HIV\u2010infected patients with lipodystrophy have higher rates of carotid atherosclerosis","volume":"34","author":"Coll B","year":"2006","journal-title":"the role of monocyte chemoattractant protein-1"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mol.0000245255.40634.b5"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(91)80962-3"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000023623.87083.4F"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.04.056"},{"key":"e_1_2_6_28_2","first-page":"24","article-title":"Serum paraoxonase\u20101 activity and concentration are influenced by human immunodeficiency virus infection","volume":"7","author":"Parra S","year":"2006","journal-title":"Atherosclerosis"},{"key":"e_1_2_6_29_2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/clinchem\/46.8.1188","article-title":"Agreement study methods based on the elimination principle for the measurement of LDL\u2010and HDL\u2010cholesterol compared with ultracentrifugation in patients with liver cirrhosis","volume":"46","author":"G\u00f3mez F","year":"2000","journal-title":"Clin Chem"},{"key":"e_1_2_6_30_2","first-page":"261","article-title":"Serum paraoxonase activity","volume":"48","author":"Ferr\u00e9 N","year":"2002","journal-title":"a new additional test for the improved evaluation of chronic liver damage"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.15.11.1812"},{"key":"e_1_2_6_32_2","first-page":"96","article-title":"Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk","volume":"21","author":"Stein JH","year":"2008","journal-title":"a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force"},{"key":"e_1_2_6_33_2","first-page":"75","article-title":"Mannheim carotid intima\u2010media thickness consensus (2004\u20132006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006","volume":"23","author":"Hennerici MG","year":"2007","journal-title":"Cerebrovasc Dis"},{"key":"e_1_2_6_34_2","first-page":"218","article-title":"The use of the Framingham equation to predict myocardial infarctions in HIV\u2010infected patients","volume":"7","author":"Law MG","year":"2006","journal-title":"comparison with observed events in the D:A:D study"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.835710"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2009.00766.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2009.00766.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T13:42:00Z","timestamp":1698673320000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2009.00766.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["10.1111\/j.1468-1293.2009.00766.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2009.00766.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}